| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/12/2011 | CA2486738C Method for identifying immunoreactive peptides |
| 07/12/2011 | CA2470078C Selective urokinase inhibitors |
| 07/12/2011 | CA2463616C Affinity enhancement agents |
| 07/12/2011 | CA2461443C Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 07/12/2011 | CA2457528C Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina) |
| 07/12/2011 | CA2446776C Self-containing lactococcus strain |
| 07/12/2011 | CA2440610C Induction of tumor immunity by variants of folate binding protein |
| 07/12/2011 | CA2421575C Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
| 07/12/2011 | CA2405438C Hepatitis b core antigen fusion proteins |
| 07/12/2011 | CA2397347C Factor vii or viia-like molecules |
| 07/12/2011 | CA2393200C Methods for targeting cells that express fibroblast growth receptor-3 or-2 |
| 07/12/2011 | CA2392046C Biglycan and uses thereof in stabilizing dystrophin associated protein complexes |
| 07/12/2011 | CA2376375C Method and composition for inhibiting cardiovascular cell proliferation |
| 07/12/2011 | CA2364095C Production of radial glial cells |
| 07/12/2011 | CA2362927C Novel albumin-free factor viii formulations |
| 07/12/2011 | CA2355399C Peptides and peptide analogues designed from hfe protein and their uses in the treatment of iron overload diseases |
| 07/12/2011 | CA2352286C Intracellular targeted delivery of compounds by 70 kd heat shock protein |
| 07/12/2011 | CA2346384C Method for prevention and/or cosmetic treatment of skin striae and use in dermatology |
| 07/12/2011 | CA2341336C Elongase genes and uses thereof |
| 07/12/2011 | CA2325058C Mammalian tolloid-like gene and protein |
| 07/12/2011 | CA2312274C Isolated dna encoding human h3 histamine receptor |
| 07/12/2011 | CA2302874C Jnk3 modulators and methods of use |
| 07/12/2011 | CA2291514C Methods for evaluating tissue morphogenesis and activity |
| 07/12/2011 | CA2277850C Genetic alterations associated with cancer |
| 07/12/2011 | CA2220442C Chromatin regulator genes |
| 07/12/2011 | CA2162262C Methods for treating muscle diseases and disorders |
| 07/07/2011 | WO2011082335A2 Purified bowman-birk protease inhibitor proteins isolated from a soy processing stream |
| 07/07/2011 | WO2011082328A1 Methods for performing a coronary artery bypass graft procedure |
| 07/07/2011 | WO2011082324A1 Methods for the prevention or treatment of vessel occlusion injury |
| 07/07/2011 | WO2011082187A1 Methods for modulating a pdgf-aa mediated biological response |
| 07/07/2011 | WO2011081928A2 Compositions and methods for altering cocaine esterase activity |
| 07/07/2011 | WO2011081915A2 Methods for treating erectile dysfunction in patients with insulin-dependent diabetes |
| 07/07/2011 | WO2011081904A1 Delivery of transthyretin across the blood-brain barrier as a treatment for alzheimer's disease |
| 07/07/2011 | WO2011081716A1 Topical acyl glutathione formulations |
| 07/07/2011 | WO2011081715A1 Topical acyl glutathione psoriasis formulations |
| 07/07/2011 | WO2011081523A1 Interferon analogs |
| 07/07/2011 | WO2011081465A2 Pharmaceutical composition for suppression of vascularization |
| 07/07/2011 | WO2011081443A2 Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof |
| 07/07/2011 | WO2011080947A1 Composition for improving brain function and method for improving brain function |
| 07/07/2011 | WO2011080887A1 Sebum secretion-blocking composition, and food or beverage containing same |
| 07/07/2011 | WO2011080733A1 Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof |
| 07/07/2011 | WO2011079431A1 Fusion protein with telomerase inhibiting activity, preparation method and use thereof |
| 07/07/2011 | WO2011066511A8 Synthetic apoa-1 mimetic amphipathic peptides and methods of use thereof |
| 07/07/2011 | WO2011059758A3 Apls for treating arthritis |
| 07/07/2011 | WO2011057027A3 Method for treating heart failure with stresscopin-like peptides |
| 07/07/2011 | WO2011052883A9 Method for activating a natural killer cell by adjusting the expression of the socs2 gene |
| 07/07/2011 | WO2011038066A4 Novel npr-b agonists |
| 07/07/2011 | WO2011035330A4 Oxytocin receptor agonists |
| 07/07/2011 | WO2011032161A8 Vaccines directed to langerhans cells |
| 07/07/2011 | WO2011031561A3 Nucleic acid molecules and uses thereof |
| 07/07/2011 | WO2011021916A3 Use of egf-like domain of heregulin beta 1 peptide |
| 07/07/2011 | WO2011021833A3 Composition for preventing or treating inflammation |
| 07/07/2011 | WO2011014707A3 Therapeutic agents for reducing parathyroid hormone levels |
| 07/07/2011 | WO2011010098A3 Methods |
| 07/07/2011 | WO2011007359A3 Antigen specific multi epitope -based anti-infective vaccines |
| 07/07/2011 | WO2010136766A3 Use of nlee for the treatment of autoimmune and inflammatory disorders, targetting nf - kappa b |
| 07/07/2011 | WO2010091373A8 Trimeric hiv fusion inhibitors for treating or preventing hiv infection |
| 07/07/2011 | WO2010057275A8 Cyclic peptides and uses thereof |
| 07/07/2011 | WO2010011767A3 Compositions and methods for treating symptoms associated with menopause, hormonal variations and arthritis |
| 07/07/2011 | US20110166545 Apoptosis-inducing agent for prostate cancer cells |
| 07/07/2011 | US20110166417 Method and device for repair of degenerative cartilage |
| 07/07/2011 | US20110166322 Alpha-conotoxin peptides |
| 07/07/2011 | US20110166320 Somatostatin analogues |
| 07/07/2011 | US20110166178 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase |
| 07/07/2011 | US20110166145 Stabilization of hypoxia inducible factor (HIF) alpha |
| 07/07/2011 | US20110166085 Composition comprising carbohydrates and peptides which comprise tryptophan |
| 07/07/2011 | US20110166084 Controlled release composition and method of producing the same |
| 07/07/2011 | US20110166083 Peptide analogues, particularly for the treatment of chronic pain |
| 07/07/2011 | US20110166082 Antisense composition and method for treating muscle atrophy |
| 07/07/2011 | US20110166081 Alpha-dystroglycan as a Protein Therapeutic |
| 07/07/2011 | US20110166080 Deuterated cyclosporine analogs and methods of making the same |
| 07/07/2011 | US20110166079 Methods of treating cancer with apoe peptides |
| 07/07/2011 | US20110166078 Oligosaccharide compounds for use in mobilising stem cells |
| 07/07/2011 | US20110166077 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 07/07/2011 | US20110166076 Antigen-binding proteins that inhibit superantigens for the treatment of skin diseases |
| 07/07/2011 | US20110166075 Method of treating degenerative disorders of the nervous system by administration of fibrinogen fragment |
| 07/07/2011 | US20110166074 Cln2 treatment of alzheimer's disease |
| 07/07/2011 | US20110166073 Anti-hypertensive agent |
| 07/07/2011 | US20110166072 Polypeptides Selective for avB3 Integrin, Including Pegylated Polypeptides, And Pharmaceutical Uses Thereof |
| 07/07/2011 | US20110166071 Method for synthesizing thymosins |
| 07/07/2011 | US20110166070 Method of preventing premature delivery |
| 07/07/2011 | US20110166069 Compositions and methods for stimulating gastrointestinal motility |
| 07/07/2011 | US20110166068 Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Pro-phylaxis of Heart Failure |
| 07/07/2011 | US20110166067 Methods for inhibition of scarring |
| 07/07/2011 | US20110166066 Catestatin (cst) and its variants for treatment of cardiovascular and metabolic disorders |
| 07/07/2011 | US20110166065 Modulation of glucose-6-phosphatase translocase expression |
| 07/07/2011 | US20110166064 Halogen-stabilized insulin |
| 07/07/2011 | US20110166063 Polymer conjugates of therapeutic peptides |
| 07/07/2011 | US20110166062 Gip-based mixed agonists for treatment of metabolic disorders and obesity |
| 07/07/2011 | US20110166061 Long lasting fusion peptide inhibitors for hiv infection |
| 07/07/2011 | US20110166060 Tympanic membrane permeating ear drops and uses thereof |
| 07/07/2011 | US20110166059 Means and methods for evaluating a therapy with a p38 map kinase inhibitor |
| 07/07/2011 | US20110166058 Organic compositions to treat hsf1-related diseases |
| 07/07/2011 | US20110165659 Biological products |
| 07/07/2011 | US20110165653 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 07/07/2011 | US20110165584 Variable Lymphocyte Receptors, Related Polypeptides and Nucleic Acids and Uses Thereof |
| 07/07/2011 | US20110165265 Trail variants for treating cancer |
| 07/07/2011 | US20110165262 Reducing drug dependence or addiction |
| 07/07/2011 | US20110165258 Polymeric delivery systems for active agents |
| 07/07/2011 | US20110165250 Compositions and methods for treatment of neoplastic disease |